Trial intelligence / Profile preview

Sirolimus for Propranolol-resistant Infantile Hepatic Hemangioendothelioma

NCT04406870Phase 4Unknown

Start
Jul 2020
Primary completion
Jun 2024
Countries
1
01

Overview

A Phase 4 trial of sirolimus in Hepatic epithelioid hemangioendothelioma (HEHE). Status: unknown.

02

Drugs

sirolimus
03

Conditions

Hepatic epithelioid hemangioendothelioma (HEHE)

Beyond the preview

Go deeper on NCT04406870.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04406870.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call